Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Drug Addiction
Resources
Basic InformationLatest News
Drug May Help Surgical Patients Stop Opioids SoonerSmokers 10 Times More Likely to Use Pot Daily'Pill Mill' Docs Only Partly to Blame for Opioid EpidemicChronic Pain Common Among Those Who OD on OpioidsPot May Alter Brain Function of Some With HIVIs Meth Use Destroying Vets' Hearts?Health Tip: Spread Awareness of the Opioid EpidemicOpioid Manufacturers to Provide Doctor TrainingMost Opioid Use Concentrated in Top 10 Percent of UsersMeth Abuse Could Up Stroke Risk in Younger UsersLonger Prescriptions Make Opioid Abuse More Likely: StudyMany Prescribed Opioids Even After OverdoseIs Infant Drug Withdrawal Likelier When Opioids Used With Psychiatric Drugs?Doctors Still Overprescribing Opioids in U.S.ACOG: Opioid Agonist Rx First Choice in Affected PregnanciesAt-Risk Pain Patients Can Cut Opioid Use With Psychology ToolsRx Changes, Counseling, Regular Visits Can Cut Opioid DeathsSharp Rise Among Women for Opioid-Related HospitalizationsOpioid-Linked Hospitalizations Rising Fastest for Women: StudyMedical Costs Soar for U.S. Babies Born Addicted to OpioidsHeart Infections Spike as Injection-Drug Abuse Climbs: CDCMarijuana May Make Your Gums Go to PotMeth Addicts' Hearts May Improve If They QuitNew FDA Head Outlines 'Forceful Steps' Against Opioid CrisisChecking Patient's Drug History May Help Curb Opioid AbuseERs May Need to Rethink Opioid Prescription PracticesNew Hepatitis C Infections Hit 15-Year High: CDCBabies Born Addicted to Opioids Often Struggle With LearningAMA Urges Doctors to Talk About Safe Opioid Storage, DisposalInitial Rx Can Affect Likelihood of Long-Term Opioid UseOpioid Dependence Can Start in Just a Few DaysWhen Cocaine's in the Mix, Safe Sex May Not BeKids Born to Opioid-Addicted Moms Seem to Fare Poorly in SchoolU.S. Report Cites the Good and Bad on MarijuanaVomiting Disorder on Rise in Weed-Friendly ColoradoPot Use in Pregnancy on the Upswing, Study Finds
Links

ACOG: Opioid Agonist Rx First Choice in Affected Pregnancies


HealthDay News
Updated: Jul 28th 2017

new article illustration

FRIDAY, July 28, 2017 (HealthDay News) -- While opioid agonist pharmacotherapy continues to be the recommended therapy for pregnant women with an opioid use disorder, medically supervised withdrawal can be considered under the care of a physician experienced in perinatal addiction treatment and with informed consent, according to a committee opinion published in the August issue of Obstetrics & Gynecology.

Maria A. Mascola, M.D., M.P.H., and colleagues from the American College of Obstetrics and Gynecology Committee on Obstetric Practice and the American Society of Addiction Medicine present ways to address opioid use in pregnancy, which has escalated dramatically in recent years.

The authors note that pregnancy offers an opportunity to identify and treat women with substance use disorders. Substance use screening should be universal, form part of comprehensive obstetric care, and be performed at the first prenatal visit. Opioid agonist pharmacotherapy is recommended for pregnant women with opioid use disorder, and is preferable to medically supervised withdrawal. The authors note there may be a select group of women who make an informed choice of medically supervised withdrawal, which should be under the care of an experienced physician and include long-term follow-up and support to help prevent relapse. Pediatric care providers should monitor infants born to women who used opioids during pregnancy for neonatal abstinence withdrawal syndrome.

"Medication-assisted treatment improves adherence to prenatal care and addiction treatment programs and has been shown to reduce the risk of pregnancy complications," Mascola said in a statement.

Abstract/Full Text